Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 101002
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.101002
Table 1 Baseline characteristics of the patients, n (%)
Variables
Pre-matched corhort
Matched corhort
EFTR, n = 362
SR, n = 211
P value
SMD
EFTR, n = 95
SR, n = 95
P value
SMD
Age (years), mean ± SD58.98 ± 8.1459.07 ± 10.610.9060.01059.79 ± 8.9058.64 ± 9.130.3280.127
Sex
    Males123 (34.0)86 (40.8)0.1240.14037 (38.9)37 (38.9)1.000< 0.001
    Females239 (66.0)125 (59.2)58 (61.1)58 (61.1)
Tumor location
    Cardia21 (5.8)5 (2.4)< 0.0010.7434 (4.2)3 (3.2)0.9460.088
    Fundus208 (57.5)60 (28.4)36 (37.9)37 (38.9)
    Body113 (31.2)100 (47.4)44 (46.3)42 (44.2)
    Antrum20 (5.5)46 (21.8)11 (11.6)13 (13.7)
Growth pattern
    Endophytic276 (76.2)147 (69.7)0.1030.14870 (73.7)67 (70.5)0.7460.070
    Exophytic86 (23.8)64 (30.3)25 (26.3)28 (29.5)
Tumor size (cm), mean ± SD1.73 ± 0.843.08 ± 1.11< 0.0011.3712.57 ± 11.12.62 ± 1.150.7630.044
Modified NIH score
    Very low risk284 (78.5)42 (19.9)< 0.0011.45032 (33.7)34 (35.8)0.9500.086
    Low risk70 (19.3)141 (66.8)55 (57.9)53 (55.8)
    Intermediate risk5 (1.4)18 (8.5)5 (5.3)4 (4.2)
    High risk3 (0.8)10 (4.7)3 (3.2)4 (4.2)